Nintedanib treatment for pulmonary fibrosis after coronavirus disease 2019

A 78‐year‐old Japanese woman with no smoking history suffered from near‐fatal coronavirus disease 2019 (COVID‐19) requiring four‐week invasive mechanical ventilation, with subsequent radiological features of pulmonary fibrosis. Although methylprednisolone gradually improved her respiratory condition...

Full description

Saved in:
Bibliographic Details
Published inRespirology case reports Vol. 9; no. 5; pp. e00744 - n/a
Main Authors Ogata, Hiroaki, Nakagawa, Taisuke, Sakoda, Soichiro, Ishimatsu, Akiko, Taguchi, Kazuhito, Kadowaki, Masako, Moriwaki, Atsushi, Yoshida, Makoto
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.05.2021
John Wiley & Sons, Inc
Wiley
Subjects
Acute respiratory distress syndrome
Case Report
Case Reports
coronavirus disease 2019
Coronaviruses
COVID-19
Enteral nutrition
Hospitals
Intubation
Lung diseases
nintedanib
Oxygen therapy
Pandemics
Patients
Pulmonary fibrosis
Rehabilitation
Respiratory diseases
severe acute respiratory syndrome coronavirus 2
Tomography
Vascular endothelial growth factor
Ventilators
Acute respiratory distress syndrome
nintedanib
severe acute respiratory syndrome coronavirus 2
coronavirus disease 2019
pulmonary fibrosis
Online AccessGet full text

Cover

Abstract A 78‐year‐old Japanese woman with no smoking history suffered from near‐fatal coronavirus disease 2019 (COVID‐19) requiring four‐week invasive mechanical ventilation, with subsequent radiological features of pulmonary fibrosis. Although methylprednisolone gradually improved her respiratory condition, her oxygenation and exercise tolerance had drastically deteriorated, necessitating high‐flow nasal cannula oxygen therapy. In parallel with tapering systemic steroid, the patient was treated with nintedanib. Three months later, the patient was able to walk with a walking aid using oxygen at 4 L/min. The present case is an indication that nintedanib might provide a novel therapeutic approach for managing post‐COVID‐19 fibrosis, although further studies are warranted. Pulmonary fibrosis after coronavirus disease 2019 (COVID‐19) recovery is becoming an emerging threat to public health worldwide. Given the present case, nintedanib might provide a novel therapeutic approach for managing post‐COVID‐19 fibrosis, although further studies are warranted.
AbstractList A 78‐year‐old Japanese woman with no smoking history suffered from near‐fatal coronavirus disease 2019 (COVID‐19) requiring four‐week invasive mechanical ventilation, with subsequent radiological features of pulmonary fibrosis. Although methylprednisolone gradually improved her respiratory condition, her oxygenation and exercise tolerance had drastically deteriorated, necessitating high‐flow nasal cannula oxygen therapy. In parallel with tapering systemic steroid, the patient was treated with nintedanib. Three months later, the patient was able to walk with a walking aid using oxygen at 4 L/min. The present case is an indication that nintedanib might provide a novel therapeutic approach for managing post‐COVID‐19 fibrosis, although further studies are warranted. Pulmonary fibrosis after coronavirus disease 2019 (COVID‐19) recovery is becoming an emerging threat to public health worldwide. Given the present case, nintedanib might provide a novel therapeutic approach for managing post‐COVID‐19 fibrosis, although further studies are warranted.
A 78‐year‐old Japanese woman with no smoking history suffered from near‐fatal coronavirus disease 2019 (COVID‐19) requiring four‐week invasive mechanical ventilation, with subsequent radiological features of pulmonary fibrosis. Although methylprednisolone gradually improved her respiratory condition, her oxygenation and exercise tolerance had drastically deteriorated, necessitating high‐flow nasal cannula oxygen therapy. In parallel with tapering systemic steroid, the patient was treated with nintedanib. Three months later, the patient was able to walk with a walking aid using oxygen at 4 L/min. The present case is an indication that nintedanib might provide a novel therapeutic approach for managing post‐COVID‐19 fibrosis, although further studies are warranted.
A 78-year-old Japanese woman with no smoking history suffered from near-fatal coronavirus disease 2019 (COVID-19) requiring four-week invasive mechanical ventilation, with subsequent radiological features of pulmonary fibrosis. Although methylprednisolone gradually improved her respiratory condition, her oxygenation and exercise tolerance had drastically deteriorated, necessitating high-flow nasal cannula oxygen therapy. In parallel with tapering systemic steroid, the patient was treated with nintedanib. Three months later, the patient was able to walk with a walking aid using oxygen at 4 L/min. The present case is an indication that nintedanib might provide a novel therapeutic approach for managing post-COVID-19 fibrosis, although further studies are warranted.A 78-year-old Japanese woman with no smoking history suffered from near-fatal coronavirus disease 2019 (COVID-19) requiring four-week invasive mechanical ventilation, with subsequent radiological features of pulmonary fibrosis. Although methylprednisolone gradually improved her respiratory condition, her oxygenation and exercise tolerance had drastically deteriorated, necessitating high-flow nasal cannula oxygen therapy. In parallel with tapering systemic steroid, the patient was treated with nintedanib. Three months later, the patient was able to walk with a walking aid using oxygen at 4 L/min. The present case is an indication that nintedanib might provide a novel therapeutic approach for managing post-COVID-19 fibrosis, although further studies are warranted.
Abstract A 78‐year‐old Japanese woman with no smoking history suffered from near‐fatal coronavirus disease 2019 (COVID‐19) requiring four‐week invasive mechanical ventilation, with subsequent radiological features of pulmonary fibrosis. Although methylprednisolone gradually improved her respiratory condition, her oxygenation and exercise tolerance had drastically deteriorated, necessitating high‐flow nasal cannula oxygen therapy. In parallel with tapering systemic steroid, the patient was treated with nintedanib. Three months later, the patient was able to walk with a walking aid using oxygen at 4 L/min. The present case is an indication that nintedanib might provide a novel therapeutic approach for managing post‐COVID‐19 fibrosis, although further studies are warranted.
Author Nakagawa, Taisuke
Ishimatsu, Akiko
Sakoda, Soichiro
Taguchi, Kazuhito
Moriwaki, Atsushi
Ogata, Hiroaki
Yoshida, Makoto
Kadowaki, Masako
AuthorAffiliation 1 Department of Respiratory Medicine National Hospital Organization Fukuoka National Hospital Fukuoka Japan
2 Department of Infectious Diseases National Hospital Organization Fukuoka National Hospital Fukuoka Japan
AuthorAffiliation_xml – name: 2 Department of Infectious Diseases National Hospital Organization Fukuoka National Hospital Fukuoka Japan
– name: 1 Department of Respiratory Medicine National Hospital Organization Fukuoka National Hospital Fukuoka Japan
Author_xml – sequence: 1
  givenname: Hiroaki
  orcidid: 0000-0002-6932-747X
  surname: Ogata
  fullname: Ogata, Hiroaki
  email: md105020@gmail.com
  organization: National Hospital Organization Fukuoka National Hospital
– sequence: 2
  givenname: Taisuke
  surname: Nakagawa
  fullname: Nakagawa, Taisuke
  organization: National Hospital Organization Fukuoka National Hospital
– sequence: 3
  givenname: Soichiro
  surname: Sakoda
  fullname: Sakoda, Soichiro
  organization: National Hospital Organization Fukuoka National Hospital
– sequence: 4
  givenname: Akiko
  surname: Ishimatsu
  fullname: Ishimatsu, Akiko
  organization: National Hospital Organization Fukuoka National Hospital
– sequence: 5
  givenname: Kazuhito
  surname: Taguchi
  fullname: Taguchi, Kazuhito
  organization: National Hospital Organization Fukuoka National Hospital
– sequence: 6
  givenname: Masako
  surname: Kadowaki
  fullname: Kadowaki, Masako
  organization: National Hospital Organization Fukuoka National Hospital
– sequence: 7
  givenname: Atsushi
  surname: Moriwaki
  fullname: Moriwaki, Atsushi
  organization: National Hospital Organization Fukuoka National Hospital
– sequence: 8
  givenname: Makoto
  surname: Yoshida
  fullname: Yoshida, Makoto
  organization: National Hospital Organization Fukuoka National Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33815804$$D View this record in MEDLINE/PubMed
BookMark eNp1kl9rFTEQxYNUbK0FP4Es-OLLXifZ7G7yIsjF1kpRKPoc8mdSc9m7uSa7lX57s962tqJPCWd-OZzJzHNyMMYRCXlJYUUB2NtkE1v1nD8hRwxaWjeNgIMH90NykvMGACgtEqXPyGGRaSuAH5FPn8M4odNjMNWUUE9bHKfKx1Tt5mEbR51uKh9MijnkSvsJU2VjKvp1SHOuXMioM1YMqHxBnno9ZDy5PY_Jt9MPX9cf64svZ-fr9xe17Zqe17LxnCNjTnfeIG2pEyAN9aXqHZiOe9bQXjYSOy-p72UnRMOZaK3QGjrXHJPzva-LeqN2KWxLSBV1UL-FmK6UTlOwAypOsQXbIYBxnPtWUmMaI9AJbKXXXfF6t_fazWaLzpbmkx4emT6ujOG7uorXSgAI1vNi8ObWIMUfM-ZJbUO2OAx6xDhnxVoQQpZ-aEFf_4Vu4pzG8lWFokK2Le-XRK8eJrqPcjeyAqz2gC1DyQm9smHSU4hLwDAoCmpZC7WshSpr8Sfi_YM7z3-g9R79GQa8-S-nLteXbOF_AdOMxRs
CitedBy_id crossref_primary_10_3390_microorganisms11040895
crossref_primary_10_1161_CIRCRESAHA_122_321879
crossref_primary_10_1016_j_matbio_2023_02_001
crossref_primary_10_1186_s12890_024_02947_5
crossref_primary_10_3390_ph17060709
crossref_primary_10_3389_fphar_2023_1143158
crossref_primary_10_4046_trd_2022_0053
crossref_primary_10_1016_j_ijid_2024_107193
crossref_primary_10_1016_j_ccm_2022_11_019
crossref_primary_10_1080_14787210_2023_2153116
crossref_primary_10_1002_ccr3_4918
crossref_primary_10_4103_lungindia_lungindia_568_21
crossref_primary_10_1080_13543784_2021_2010188
crossref_primary_10_1007_s10787_021_00903_x
crossref_primary_10_1016_j_resinv_2023_05_007
crossref_primary_10_1097_MD_0000000000028639
crossref_primary_10_1002_ptr_7535
crossref_primary_10_1080_17476348_2022_2128770
crossref_primary_10_3389_fpubh_2022_967829
crossref_primary_10_4103_atm_atm_7_23
crossref_primary_10_1155_2022_9972846
crossref_primary_10_20473_jr_v8_I_3_2022_178_184
crossref_primary_10_1016_j_hpr_2022_300666
Cites_doi 10.1136/thoraxjnl-2020-215314
10.1056/NEJMoa1908681
10.1016/S2213-2600(20)30225-3
10.1016/S0140-6736(20)30183-5
10.1016/S2213-2600(20)30222-8
ContentType Journal Article
Copyright 2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.
2021 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.
2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.
– notice: 2021 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.
– notice: 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1002/rcr2.744
DatabaseName Wiley Online Library Open Access (WRLC)
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
Coronavirus Research Database
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

Publicly Available Content Database
PubMed
MEDLINE - Academic

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Nintedanib for post‐COVID‐19 fibrosis
EISSN 2051-3380
EndPage n/a
ExternalDocumentID oai_doaj_org_article_41e50c6e00bd44f591bb3b8ed8e59fa6
PMC8008274
33815804
10_1002_rcr2_744
RCR2744
Genre caseStudy
Case Reports
GroupedDBID 0R~
1OC
24P
5VS
7X7
8-1
8FI
8FJ
AAHHS
AAZKR
ABDBF
ABUWG
ACCFJ
ACCMX
ACUHS
ACXQS
ADBBV
ADKYN
ADRAZ
ADZMN
AEEZP
AEQDE
AFKRA
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
DIK
EBS
EJD
FYUFA
GODZA
GROUPED_DOAJ
HMCUK
HYE
HZ~
IAO
IHR
INH
ITC
KQ8
M48
M~E
O9-
OK1
PIMPY
PQQKQ
PROAC
RPM
UKHRP
WIN
AAYXX
CITATION
PHGZM
PHGZT
NPM
3V.
7XB
8FK
AAFWJ
AAMMB
AEFGJ
AFPKN
AGXDD
AIDQK
AIDYY
AZQEC
COVID
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c6374-93f44e22da6fbe151d809b1fc63fd0b64f2317939e6f91f7968834285c8aa06d3
IEDL.DBID M48
ISSN 2051-3380
IngestDate Wed Aug 27 01:28:59 EDT 2025
Thu Aug 21 14:10:26 EDT 2025
Tue Aug 05 09:39:22 EDT 2025
Wed Aug 13 04:01:06 EDT 2025
Wed Feb 19 02:07:16 EST 2025
Tue Jul 01 04:17:39 EDT 2025
Thu Apr 24 23:08:31 EDT 2025
Wed Jan 22 16:30:54 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Acute respiratory distress syndrome
nintedanib
severe acute respiratory syndrome coronavirus 2
coronavirus disease 2019
pulmonary fibrosis
Language English
License Attribution
2021 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c6374-93f44e22da6fbe151d809b1fc63fd0b64f2317939e6f91f7968834285c8aa06d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Report-3
ObjectType-Case Study-4
ObjectType-Case Study-2
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
Associate Editor: Nicole Goh
ORCID 0000-0002-6932-747X
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1002/rcr2.744
PMID 33815804
PQID 2518955476
PQPubID 2034406
PageCount 3
ParticipantIDs doaj_primary_oai_doaj_org_article_41e50c6e00bd44f591bb3b8ed8e59fa6
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8008274
proquest_miscellaneous_2508891791
proquest_journals_2518955476
pubmed_primary_33815804
crossref_citationtrail_10_1002_rcr2_744
crossref_primary_10_1002_rcr2_744
wiley_primary_10_1002_rcr2_744_RCR2744
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate May 2021
PublicationDateYYYYMMDD 2021-05-01
PublicationDate_xml – month: 05
  year: 2021
  text: May 2021
PublicationDecade 2020
PublicationPlace Chichester, UK
PublicationPlace_xml – name: Chichester, UK
– name: United States
– name: Hoboken
PublicationTitle Respirology case reports
PublicationTitleAlternate Respirol Case Rep
PublicationYear 2021
Publisher John Wiley & Sons, Ltd
John Wiley & Sons, Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Ltd
– name: John Wiley & Sons, Inc
– name: Wiley
References 2020; 8
2020; 75
2019; 381
2020; 395
2020
e_1_2_4_7_1
e_1_2_4_6_1
e_1_2_4_3_1
e_1_2_4_2_1
e_1_2_4_5_1
e_1_2_4_4_1
References_xml – volume: 395
  start-page: 497
  year: 2020
  end-page: 506
  article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  publication-title: Lancet
– volume: 8
  start-page: 750
  year: 2020
  end-page: 752
  article-title: Pulmonary fibrosis secondary to COVID‐19: a call to arms?
  publication-title: Lancet Respir. Med.
– volume: 75
  start-page: 1009
  year: 2020
  end-page: 1016
  article-title: Respiratory follow‐up of patients with COVID‐19 pneumonia
  publication-title: Thorax
– volume: 381
  start-page: 1718
  year: 2019
  end-page: 1727
  article-title: Nintedanib in progressive fibrosing interstitial lung diseases
  publication-title: N. Engl. J. Med.
– volume: 8
  start-page: 807
  year: 2020
  end-page: 815
  article-title: Pulmonary fibrosis and COVID‐19: the potential role for antifibrotic therapy
  publication-title: Lancet Respir. Med.
– year: 2020
– ident: e_1_2_4_3_1
  doi: 10.1136/thoraxjnl-2020-215314
– ident: e_1_2_4_4_1
  doi: 10.1056/NEJMoa1908681
– ident: e_1_2_4_2_1
  doi: 10.1016/S2213-2600(20)30225-3
– ident: e_1_2_4_6_1
  doi: 10.1016/S0140-6736(20)30183-5
– ident: e_1_2_4_7_1
– ident: e_1_2_4_5_1
  doi: 10.1016/S2213-2600(20)30222-8
SSID ssj0001105111
Score 2.307786
Snippet A 78‐year‐old Japanese woman with no smoking history suffered from near‐fatal coronavirus disease 2019 (COVID‐19) requiring four‐week invasive mechanical...
A 78-year-old Japanese woman with no smoking history suffered from near-fatal coronavirus disease 2019 (COVID-19) requiring four-week invasive mechanical...
Abstract A 78‐year‐old Japanese woman with no smoking history suffered from near‐fatal coronavirus disease 2019 (COVID‐19) requiring four‐week invasive...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e00744
SubjectTerms Acute respiratory distress syndrome
Case Report
Case Reports
coronavirus disease 2019
Coronaviruses
COVID-19
Enteral nutrition
Hospitals
Intubation
Lung diseases
nintedanib
Oxygen therapy
Pandemics
Patients
Pulmonary fibrosis
Rehabilitation
Respiratory diseases
severe acute respiratory syndrome coronavirus 2
Tomography
Vascular endothelial growth factor
Ventilators
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PSx0xEA7iQbyU-qPtq1oiiD1tTbLJbnK0ooigB1HwFpJNhj6QfbLPV-h_30l23_IetfTS606yzM5kmC-byTeEnIAJDNLNXxAcCikcFF4AFC64EqekHJXuDt_eVdeP8uZJPa20-ko1YT09cG-4M8mjYk0VGfNBSlCGe196HYOOyoDLZNuY81Y2U_nvCsIGjOIl2ywTZ13TiW-1lGv5J9P0v4Ut_yyRXIWuOfdcvSfvBtBIz3tld8hGbHfJ1u1wLL5Hbu4S60Nw7dTTsXKcIhylL4tnXGeu-0UB98Wz-XROc1dw2iTmAvdz2i3mdDikoZilzT55vLp8uLguhiYJRVOVtSxMCVJGIYKrwEfM30Ez4zmgFALzlQREcBiEJlZgONSm0rrEPYdqtHOsCuUHstnO2viJ0BIi91xrJSOa2teeB5C-icoLiW9VE_J1aTrbDAziqZHFs-25j4VNRrZo5Ak5Hke-9KwZb4z5nqw_yhPPdX6A3reD9-2_vD8hh0vf2SH45hYhmzYIk2oUH49iDJt0FuLaOFukMam-K3GzTsjH3tWjJrhr50oz1LBeWwRrqq5L2umPTM2tE6SqceZpXi5__Xh7f3GfuBk__w8jHJBtkSptchnmIdl87RbxCKHSq_-So-I3EtIUGQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9QwDI9gSIiXiW8OBgoSgqeyJk3T5AltE9M0aXuYmHRvVdLEcNLUHu1uEv89di_XcWLwWieV69i1Ezs_M_YBbMiBbv6CFJAp6SDzEiBzwRU4hXwU3R0-O9cnl-p0Xs7TgduQyio3_8TxRx26hs7I99EPG4u-r9Jflj8z6hpF2dXUQuM-e0DQZVTSVc2r2zMWDB7QljeYs7nc75tefq6U2vJCI1j_XRHm34WSfwawowc6fsx2U-jID9Zr_YTdi-1T9vAsJcefsdNzwn4Irl14PtWPcwxK-XJ1hey7_hcH3B13w2LgY29w3hB-gbtZ9KuBp1QNR19tn7PL46_fjk6y1Coha3RRqcwWoFSUMjgNPqIXDya3XgBSIeReK8A4Dk3RRg1WQGW1MQXuPMrGOJfrULxgO23XxleMFxCFF8aUKgalfOVFAOWbWHqp8K3ljH3aiK5uEo44tbO4qtcIyLImIdco5Bl7P41crrEz7hhzSNKf6IR2PT7o-u91Mp5aiVjmjY557pElKK3wvvAmBhNLC07P2N5m7epkgkN9qzDIx0RG46GMiGtjt6IxVOVFCK0z9nK91BMnuHcXpcmRw2pLCbZY3aa0ix8jQLehwKrCmR9Hdfnnx9cXRxeE0Pj6__y_YY8kVdKMZZZ7bOe6X8W3GApd-3ejvv8GpEoK2A
  priority: 102
  providerName: ProQuest
– databaseName: Wiley Online Library Open Access (WRLC)
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9UwFA86QXwRv3d1SgaiT3VJmrTJow7HGGzIcLC3kjQ5emH0jnbXv99z0t7OixN8Kz1Jycc5Pb8kJ7_D2HtwUQDd_AUlodDKQxEUQOGjL7EK-Si6O3x6Vh1f6JNLczlFVdJdmJEfYt5wI8vI_2sycB-Gg1vS0L7t1ada6_vsAd2sJd58pb_d7q8gcJA5_a7ChwJXYmLDPSvUwabyljfKpP13Ic2_Ayb_BLLZEx09YY8nCMk_j3P-lN1L3TP28HQ6JH_OTs6IAyL6bhn4HEfOEZzy6_UVah12mQN2fTUsB55zhPOWeAz8r2W_Hvh0ZMPRZ7sX7OLo6_fD42JKmVC0VVnrwpWgdVIq-gpCQm8erXBBAkohilBpQDyHJulSBU5C7SprS1yBmNZ6L6pYvmQ73apLu4yXkGSQ1hqdotahDjKCDm0yQWn8qlmwj5uha9qJT5zSWlw1IxOyamiQGxzkBdufS16PHBp3lPlCoz_LifU6v1j1P5rJiBotkxFtlYQI2CQwToZQBpuiTcaBrxZsbzN3zWSKQ4MAzjoETTWK92cxGhGdjPgurdZUhqK9iKl1wV6NUz23BDVHGiuwhfWWEmw1dVvSLX9mom5LAKvGmh-yuvyz88354TkxNb7-34Jv2CNFsTU58HKP7dz06_QWwdFNeJet4DdTeAwf
  priority: 102
  providerName: Wiley-Blackwell
Title Nintedanib treatment for pulmonary fibrosis after coronavirus disease 2019
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Frcr2.744
https://www.ncbi.nlm.nih.gov/pubmed/33815804
https://www.proquest.com/docview/2518955476
https://www.proquest.com/docview/2508891791
https://pubmed.ncbi.nlm.nih.gov/PMC8008274
https://doaj.org/article/41e50c6e00bd44f591bb3b8ed8e59fa6
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9swED_6AWMvY9_L1gUVxvbkzpJlS3oYYy0tpZBQwgJ5M5IldYHgdE4z1v9-J8U2DctgL8b4JCOf7rifpPPvAD54ZVMf_vz1jPqEM-0Tw7xPtNUZdgkxKvw7PBoXl1N-Nctne9BV22wVuNq5tAv1pKbN4uT3z_uv6PBfWgLRz03VsBPB-T4cYjwSwT1HLciPOy0IIWgsxMvwJsE1Wdqx0D7ovBWXIn3_Lsz5d-rkQ0gbY9LFU3jSgknybTP7z2DP1c_h0ag9Ln8BV-PABmF1PTekzygnCFPJ7XqB9qebe-JxvbxczVckVgsnVWA00L_mzXpF2sMbgtFbvYTpxfn3s8ukLZ6QVEUmeKIyz7ljzOrCG4dx3cpUGepR6m1qCu4R2aFzKld4Rb1QhZQZrkXySmqdFjZ7BQf1snZvgGTeUUOlzLmznBthqPXcVC43jONb8wF86lRXVi2zeChwsSg3nMisDEouUckDOO5b3m7YNHa0OQ3a7-WB_zo-WDY3ZetOJacuT6vCpanBIflcUWMyI52VLldeFwM46uau7GyqRCgnFcIngeLjXozuFM5IdO2W69Am5H0FztYBvN5MdT8StByayxRHKLaMYGuo25J6_iNSdssAtQT2_BjN5Z8fX07OJoGz8e3_NnwHj1nIsokpmEdwcNes3XuESXdmCPuMX-NVzMQQDk_Px9eTYdxyGEb_-ANBOhUf
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcEG8WChiJxyk0cZzEPiBES6vtY1do1Uq9uXZsw0pVsiRdUP8Uv5FxHltWFG69xg9NxmPPZ3v8DcBrJ0zo_MtfRyMXMKpcoKlzgTIqxibeR_m3w-NJOjpm-yfJyRr86t_C-LDKfk1sFmpT5v6MfBP9MBfo-7L04_x74LNG-dvVPoVGaxYH9uInbtnqD3ufcXzfULq7c7Q9CrqsAkGexhkLROwYs5QalTpt0eEZHgodOSx1JtQpcwh50GqFTZ2IXCZSzmME6UnOlQpTE2O_N2CdxbiVGcD61s7ky_TyVAfhCq4ePcttSDervKLvM8ZW_F6THuAqTPt3aOafkLnxebt34U4HVsmn1rruwZot7sPNcXcd_wD2J55twqhipskyYp0gDCbzxRkqTFUXxOF-vKxnNWmykZPcMyaoH7NqUZPucoggOhAP4fha1PgIBkVZ2CdAYmcjHXGeMGsY05mOjGM6t4mmDHtNhvCuV53MO-Zyn0DjTLacy1R6JUtU8hBeLWvOW7aOK-psee0vyz2_dvOhrL7KbrpKFtkkzFMbhhpFcomItI41t4bbRDiVDmGjHzvZTfpaXpooyrEsxunq72BUYcuFr-Pjyjwn7BAet0O9lCRG9JTwECXMVoxgRdTVkmL2raEE5x7KZdjybWMu__x5Od2eek7Ip_-X_yXcGh2ND-Xh3uTgGdymPo6nCfLcgMF5tbDPEYid6xed9RM4ve4J9xvSrEfX
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkSouiDdbChiJxyls4tixc0AIWlZ90BWqqLS31I5tWKlKtkkX1L_Gr2Mmr7KicOs1dqzJeMbzOR5_Q8hLn9rQ481fzyIfcKZ9YJj3gbY6hlcwRuHd4cNpsnvM92ditkZ-9XdhMK2yXxObhdqWOf4jH0McVinEPpmMfZcW8WVn8n5xFmAFKTxp7ctptCZy4C5-wvatfre3A3P9irHJp6_bu0FXYSDIk1jyII09544xqxNvHAQ_q8LURB5avQ1Nwj3AH7Dg1CU-jbxME6ViAOwiV1qHiY1h3BvkpoxFhD4mZ_Ly_w4AF1hHer7bkI2rvGJvJecrEbApFHAVuv07SfNP8NxEv8kdcruDrfRDa2d3yZor7pGNw-5g_j7ZnyLvhNXF3NAhd50CIKaL5SmoS1cX1MPOvKznNW3qktMcuRP0j3m1rGl3TEQBJ6QPyPG1KPEhWS_Kwj0mNPYuMpFSgjvLuZEmsp6b3AnDOIwqRuRNr7os7zjMsZTGadayL7MMlZyBkkfkxdBz0fJ2XNHnI2p_aEem7eZBWX3LOsfNeOREmCcuDA2I5EUaGRMb5axyIvU6GZGtfu6yzv3r7NJYQY6hGRwXT2N04col9sEMM2SHHZFH7VQPksSAo4QKQUK5YgQroq62FPPvDTm4QlAn4c3Xjbn88-Ozo-0jZIfc_L_8z8kGuFn2eW968ITcYpjQ02R7bpH182rpngIiOzfPGtOn5OS6fe03ZdZKpw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nintedanib+treatment+for+pulmonary+fibrosis+after+coronavirus+disease+2019&rft.jtitle=Respirology+case+reports&rft.au=Ogata%2C+Hiroaki&rft.au=Nakagawa%2C+Taisuke&rft.au=Sakoda%2C+Soichiro&rft.au=Ishimatsu%2C+Akiko&rft.date=2021-05-01&rft.pub=John+Wiley+%26+Sons%2C+Ltd&rft.issn=2051-3380&rft.eissn=2051-3380&rft.volume=9&rft.issue=5&rft.epage=n%2Fa&rft_id=info:doi/10.1002%2Frcr2.744&rft.externalDBID=10.1002%252Frcr2.744&rft.externalDocID=RCR2744
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2051-3380&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2051-3380&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2051-3380&client=summon